These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9972509)

  • 41. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Focal therapy in the management of retinoblastoma: when to start and when to stop.
    Hamel P; Heon E; Gallie BL; Budning AS
    J AAPOS; 2000 Dec; 4(6):334-7. PubMed ID: 11124666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontiers in the management of retinoblastoma.
    Lin P; O'Brien JM
    Am J Ophthalmol; 2009 Aug; 148(2):192-8. PubMed ID: 19477707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.
    Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL
    Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma.
    Khetan V; Mathur G; Kumar SK; Gopal L
    Ophthalmic Genet; 2013; 34(1-2):87-9. PubMed ID: 22950453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical management of retinoblastoma.
    Shields JA; Shields CL; De Potter P
    Curr Opin Ophthalmol; 1994 Jun; 5(3):83-8. PubMed ID: 10147460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ocular and orbital complications following the treatment of retinoblastoma.
    Anteby I; Ramu N; Gradstein L; Miskin H; Pe'er J; Benezra D
    Eur J Ophthalmol; 1998; 8(2):106-11. PubMed ID: 9673480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plaque radiotherapy for residual or recurrent retinoblastoma in 91 cases.
    Shields JA; Shields CL; De Potter P; Hernandez JC; Brady LW
    J Pediatr Ophthalmol Strabismus; 1994; 31(4):242-5. PubMed ID: 7807301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoblastoma.
    Mehta M; Sethi S; Pushker N; Kashyap S; Sen S; Bajaj MS; Ghose S
    Singapore Med J; 2012 Feb; 53(2):128-35; quiz 136. PubMed ID: 22337189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current management strategies for intraocular retinoblastoma.
    Kim JW; Abramson DH; Dunkel IJ
    Drugs; 2007; 67(15):2173-85. PubMed ID: 17927283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late-onset retinoblastoma in a well-functioning fellow eye.
    de Jong PT; Mooy CM; Stoter G; Eijkenboom WM; Luyten GP
    Ophthalmology; 2006 Jun; 113(6):1040-4. PubMed ID: 16631255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
    Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
    Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
    Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
    J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinoblastoma - A comprehensive review, update and recent advances.
    Nag A; Khetan V
    Indian J Ophthalmol; 2024 Jun; 72(6):778-788. PubMed ID: 38804799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.